Despite Knowing Nexium® Causes Bones To Deteriorate And Break, They Marketed And Sold Nexium® Without Warning Consumers Of The Significant Risks Of Bone Deterioration And Fractures.

Nexium® is a prescription-strength proton pump inhibitor (“PPI”) used for the treatment of heartburn, acid reflux, ulcers and inflammation of the esophagus, which works by reducing acid in the stomach. Nexium® also, however, prevents calcium absorption which causes bone deterioration and eventual fractures.

On March 22, 2011, the FDA issued a safety alert stating use of prescription PPI's, including Nexium®, results in an increased risk of fractures. In May, 2010, the FDA mandated manufacturers of PPI's, including Nexium® , begin to include safety information and warnings about the increased risk of osteoporosis and fractures associated with PPI's.

However, as early as 2006, studies found PPI's, by reducing hydrochloric acid in the stomach, interfere with the body’s ability to absorb calcium, thus speeding up bone loss and leading to an increased number of fractures. In total, six studies have found the risk of fracture significantly increased for those patients over fifty (50) years of age who took a prescription-strength PPI, like Nexium® , or who took any PPI regularly for more than one (1) year. Specifically, use of PPI's increases the risk of fractures in women up to 34 percent.

Nexium® is AstraZeneca's largest-selling drug and the third largest-selling drug in the world. Defendants sold over $5.7 billion dollars worth of Nexium® in 2005 and $5.2 billion dollars worth in 2008. Despite knowing Nexium® causes bones to deteriorate and break, Defendants marketed and sold Nexium® without warning consumers of the significant risks of bone deterioration and fractures.

The Voss Law Firm is currently pursuing Nexium® claims for injuries related to severe bone fractures. If you have taken Nexium® and suffered severe bone fractures (broken bones), please contact us immediately for free legal advice.

Library for Nexium:

Increased Risk of Fractures Of The Hip, Wrist, And Spine With The Use Of Proton Pump Inhibitors
FDA has determined an osteoporosis and fracture warning on the over-the-counter proton pump inhibitor (PPI) medication “Drug Facts” label is not indicated.
A Serious Bone Fracture Warning Has Been Added To Nexium
The FDA announced that all proton pump inhibitors (PPIs) will now include a warning that they are very dangerous if used for a continued length of time.
Proton Pump Inhibitor Use, Hip Fracture, and Change in Bone Mineral Density in Postmenopausal Women
Proton pump inhibitor (PPI) medications have been inconsistently shown to be associated with osteoporotic fractures.
Nexium Warning: Possible Fracture Risk with High Dose, Long-term Use of Proton Pump Inhibitors
The U.S. Food and Drug Administration warned consumers and health care professionals about a possible increased risk of fractures.
Possible Increased Risk of Bone Fractures With Certain Antacid Drugs
Be aware that an increased risk of fractures of the hip, wrist, and spine have been reported in some studies of people who use PPIs.
Despite Knowing Nexium® Causes Bones To Deteriorate And Break, They Marketed And Sold Nexium® Without Warning Consumers Of The Significant Risks Of Bone Deterioration And Fractures.
If you have taken Nexium® and suffered severe bone fractures (broken bones), please contact us immediately for free legal advice. Confidential consultations.

View All

Free Case Review

Fill out the form below to claim your FREE CONFIDENTIAL case review. To expedite your case evaluation please provide us with the name of the drug or device on which you are seeking advice.